Safety and Immunogenicity of the rVSV ΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Years and in Their Adults and/or Children Relatives Living in Lambaréné, Gabon
Condition: Ebola Virus Disease Intervention: Biological: rVSVΔG-ZEBOV-GP, V920 Sponsors: Centre de Recherche Médicale de Lambaréné; Merck Sharp & Dohme Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials